These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2654809)

  • 21. PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways.
    Alisi A; Spaziani A; Anticoli S; Ghidinelli M; Balsano C
    Cell Signal; 2008 Mar; 20(3):534-42. PubMed ID: 18164587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S; Goldschmidt-Clermont PJ; Dong C
    Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIBG, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21(cip1).
    Yau L; Litchie B; Zahradka P
    Exp Cell Res; 2004 Dec; 301(2):320-30. PubMed ID: 15530866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.
    Sejersen T; Sümegi J; Ringertz NR
    J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong induction of the Tis11B gene in myogenic differentiation.
    Busse M; Schwarzburger M; Berger F; Hacker C; Munz B
    Eur J Cell Biol; 2008 Jan; 87(1):31-8. PubMed ID: 17889962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of myogenic determination factor 1 expression by cell-cell contact.
    Song A; Daub R; Harrington MA
    J Cell Physiol; 1993 Aug; 156(2):257-63. PubMed ID: 8344984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts.
    Meacci E; Nuti F; Donati C; Cencetti F; Farnararo M; Bruni P
    J Cell Physiol; 2008 Jan; 214(1):210-20. PubMed ID: 17654519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle.
    Ohtake Y; Tojo H; Seiki M
    J Cell Sci; 2006 Sep; 119(Pt 18):3822-32. PubMed ID: 16926191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
    Gossett LA; Zhang W; Olson EN
    J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation.
    Rajan S; Chu Pham Dang H; Djambazian H; Zuzan H; Fedyshyn Y; Ketela T; Moffat J; Hudson TJ; Sladek R
    Physiol Genomics; 2012 Feb; 44(2):183-97. PubMed ID: 22147266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of type 2C protein phosphatase gene during myogenic differentiation of C3H10T1/2 cells.
    Ohishi S; Endo M; Kobayashi T; Terasawa T; Murakami T; Onoda M; Ohnishi M; Itoh T; Tsuiki S; Tamura S
    Biochem Int; 1992 Oct; 28(2):345-51. PubMed ID: 1280951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
    Olson EN; Spizz G; Tainsky MA
    Mol Cell Biol; 1987 Jun; 7(6):2104-11. PubMed ID: 3600660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.
    Lassar AB; Thayer MJ; Overell RW; Weintraub H
    Cell; 1989 Aug; 58(4):659-67. PubMed ID: 2548731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras.
    Weyman CM; Ramocki MB; Taparowsky EJ; Wolfman A
    Oncogene; 1997 Feb; 14(6):697-704. PubMed ID: 9038377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene.
    Sternberg EA; Spizz G; Perry ME; Olson EN
    Mol Cell Biol; 1989 Feb; 9(2):594-601. PubMed ID: 2651901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1.
    Tapscott SJ; Lassar AB; Davis RL; Weintraub H
    Science; 1989 Aug; 245(4917):532-6. PubMed ID: 2547249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of Ras signaling through NFkappaB on skeletal myogenesis.
    Mitin N; Kudla AJ; Konieczny SF; Taparowsky EJ
    Oncogene; 2001 Mar; 20(11):1276-86. PubMed ID: 11313872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.